Manejo anestésico del paciente con miocardiopatía hipertrófica obstructiva sometido ablación alcohólica transeptal

Obstructive hypertrophic cardiomyopathy is a genetic entity that can occur at any stage of life. Multiple genetic alterations have been described as responsible, most of which affect constituent proteins of the sarcomere. The clinic is also heterogeneous, although a large percentage of patients are asymptomatic, is one of the leading causes of sudden death. The most important alteration lies in the obstruction of left ventricle outflow tract. Initially, treatment is started with pharmacological strategies. However, if it isn't effective, invasived therapy are recomended. Interventricular septal myomectomy is the traditional option, but in case of contraindication for comorbidity the alcoholic ablation coronary branch is indicated, causing necrosis of this region. In this article we describe the anesthesic management of a patient undergoing this technique, considering the moderate sedation as a valid alternative.